Abstract
Here, we describe a challenging scale-up synthesis of the highly functionalized echinocandin ASP9726 (1) starting from the natural product FR901379 (3), the same raw material of micafungin (2). The synthesis demanded various difficult chemoselective transformations due to the complexity and the unique property of the cyclic poly-peptide core. In the present study, we discovered an efficient, high-yielding route to ASP9726 (1) that is suitable for large-scale production. Namely, dehydration of carboxamide (13) to nitrile (14) was accomplished by the use of EDC ∙ HCl with pyridine. Further, the sequential nitrile reduction and debenzylation was succeeded with Sponge Nickel- Pd/Ccatalyst mixed catalyst condition. Reductive amination between primary amine (16) with dihydroxyacetone (DHA) was accomplished using 2-picoline borane complex in MeOH, yielding 66.6 kg of peptide core unit (17). After the palmityl chain cleavage by bioconversion, the coupling between the core peptide unit (18) and side chain (9) was achieved by tert-butyl amine borane complex. Consequently, highly pure ASP9726 (1) was obtained in a practical manner without using silica gel or ODS column chromatography purification in any step. The number of step was reduced to 10-steps from 14-steps and the overall yield was drastically increased to 13.8% from 0.71% in comparison with the prior synthesis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
(a) Tawara, S.; Ikeda, F.; Maki, K.; Morishita, Y.; Otomo, K.; Teratani, N.; Goto, T.; Tomishima, M.; Ohki, H.; Yamada, A.; Kawabata, K.; Takasugi, H.; Sakane, K.; Tanaka H.; Matsumoto, F.; Kuwahara, S. Antimicrob. Agents Chemother. 2000, 44, 57. (b) Ikeda F.; Wakai Y.; Matsumoto, S.; Maki K.; Watabe E.: Tawara, S.; Goto, T.; Watanabe Y.; Matsumoto, F.; Kuwahara, S. Antimicrob. Agents Chemother. 2000, 44, 614. (c) Matsumoto, S.; Wakai Y.; Nakai T.; Hatano, K.; Ushitani T.; Ikeda F.; Tawara, S.; Goto, T.; Matsumoto, F.; Kuwahara, S. Antimicrob. Agents Chemother. 2000, 44, 619. (d) Hatano, K.; Morishita, Y.; Nakai, T.; Ikeda, F. J. Antibiot. 2002, 55, 219. (e) Tomishima, M.; Ohki H.; Yamada A.; Takasugi H.; Maki K.; Tawara S.; Tanaka, H. J. Antibiot. 1999, 52, 674. (f) Morikawa, H.; Tomishima, M.; Kayakiri, N.; Araki, T.; Barrett, D.; Akamatsu, S.; Matsumoto, S.; Uchida, S.; Naka, T.; Takeda, S.; Maki, K. Bioorganic and Medicinal Chem. Lett., 2014, 24, 1172.
(a) Boeck, L. D.; Fukuda, D. S.; Abbott, B. J.; Debono, M. J. Antibiot. 1989, 42, 382; (b) Debono, M.; Abbott, B. J.; Fukuda, D. S.; Barnhart, M.; Willard, . K. E.; Molloy, R. M.; Michel, K. H.; Turner, J. R.; Butler, T. F.; Hunt, A. H. J. Antibiot. 1989, 42, 389.
Yoshida, S.; Hayashida, J.; Morinaga, Y.; Mizobata, S.; Okada, A.; Kawai, K.; Tanoue, S.; Nakata, T.; Kitayama, M.; Ohigashi, A.; Matsuura, M.; Takahashi, T.; Ieda, S. and Okada M. Org. Process Res. Dev., 2014, 18, 725.
Yoshida, S.; Ohigashi, A.; Morinaga, Y., Hashimoto, H.; Takahashi, Y.; Ieda, S.; Okada, M. Org. Process Res. Dev., 2013, 17, 1252.
(a) Leonard, Jr., W. R; Belyk, K. M.; Conlon, S.A.; Bender, D. R.; DiMichele, L. M; Liu, J.; Hughes, D. L. J, Org. Chem., 2007, 72, 2335. (b) Journet, M.; Cai, D.; DiMichele, L. M.; Hughes, D. L.; Larsen, R. D.; Verhoeven, T. R.; Reider, P. J. J, Org. Chem., 1999, 64, 2411.
Kwang-Chung, L.; Yen-Shih, T.; Hao-Ling, F. US20100168415A1.
Pd catalysts (Kawaken Fine Chemicals Co., Ltd.) http://www.kawakenfc.co.jp/en/products/fine/index.php/search?list=1&cell003=+Precious+Metal+Catalysts&cell030=&keyword=.
Nickel catalysts (Kawaken Fine Chemicals Co., Ltd.) http://www.kawakenfc.co.jp/en/products/fine/index.php/search?list=1&cell003=Sponge+Nickel&cell030=&keyword=.
(a) Pelter, A.; Rosser, R.M. J. Chem. Soc. Perkin Trans. I, 1984, 717. (b) Bomann, M. D.; Guch, I. C.; DiMare, M. J. Org. Chem., 1995, 60, 5995. (c) Moormanna, A. E. Synthetic Communications, 1993, 23, 789.
(a) Cosenza, V. A.; Navarro, D. A.; Stortz, C. A. ARKIVOC 2011 (vii) 182. (b) Ruhaak, L. R.; Steenvoorden, E.; Koeleman, C. A. M.; Deelder, A. M.; Wuhrer, M. Proteomics. 2010 10, 2330. (c) Sato, S.; Sakamoto, T.; Miyazawa E.; Kikugawa, Y. Tetrahedron, 2004, 60, 7899. (d) Kawase, Y.; Yamagishi, T.; Kutsuma, T.; Ueda, K.; Iwakuma, T.; Nakata, T.; Yokomatsu, T. Heterocycles, 2009, 78, 463. (e) https://www.junsei.co.jp/upfile/topics/52/52-2.pdf.
Matos, K; Burkhardt, E. R. Pharmaceutical process chemistry section 6, Direct Reductive Amination with Amine Boranes, 2011, 127.
Ueda S, Kinoshita M, Tanaka F, Tsuboi M, Shimizu S, Oohata N, Hino M, Yamada M, Isogai Y, Hashimoto S. J. Biosci. Bioeng. 2011, 112, 409.
Acknowledgements
We would like to thank Dr. Masaki Tomishima, Dr. Natsuko Kayakiri and Mr. Hiroshi Morikawa for their helpful discussions about the medicinal synthetic method for 1. We also appreciated Dr. Tatsuhiro Tokunaga for meaningful advice of NMR study.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Yoshida, S. et al. (2017). A Challenging Synthesis of the Highly Functionalized Echinocandin ASP9726: A Successor of Micafungin—How Can We Achieve the Large-Scale Synthesis?. In: Tomioka, K., Shioiri, T., Sajiki, H. (eds) New Horizons of Process Chemistry. Springer, Singapore. https://doi.org/10.1007/978-981-10-3421-3_16
Download citation
DOI: https://doi.org/10.1007/978-981-10-3421-3_16
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-3420-6
Online ISBN: 978-981-10-3421-3
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)